Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LOX | P28300 | 1/20 | 0.44 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14740533 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL1003032 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL411130 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL818935 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL1004438 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL1003333 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL5203287 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL645518 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX | |
| SCHEMBL818520 | 1.00 | — | — | |
| SCHEMBL16037042 | 1.00 | ALDH1A1 (0.58) | ALDH1A1TDP1TSHRMAPTLOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107239006-A | Anticorrosive additive stripping liquid controlling composition, flat board and its manufacture method and display device | 东友精细化工有限公司 | 2017-10-10 | — | — | CN | claimed |
| EP-3184171-B1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2019-03-20 | — | — | EP | disclosed |
| US-10144752-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2018-12-04 | — | — | US | disclosed |
| US-20170305945-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2017-10-26 | — | — | US | disclosed |
| US-9732106-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2017-08-15 | — | — | US | disclosed |
| EP-3184171-A1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | Chevron Phillips Chemical Company LP (US) | 2017-06-28 | — | — | EP | disclosed |
| EP-2519532-B1 | PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2017-03-08 | — | — | EP | disclosed |
| CN-106397268-A | A manufacturing method of a dicyano compound | 宇部兴产株式会社 | 2017-02-15 | — | — | CN | disclosed |
| US-9562183-B2 | Use of compounds with nitrogen-containing functional groups for thermal energy storage | ARKEMA FRANCE (FR) | 2017-02-07 | — | — | US | disclosed |
| US-20160168180-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2016-06-16 | — | — | US | disclosed |
| EP-1189876-A2 | PROCESS FOR HYDROGENATING DINITRILES IN AMINONITRILES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-03-27 | — | — | EP | disclosed |
| US-20010047104-A1 | Partial hydrogenation of a dinitrile by contacting with a hydrogen-containing fluid in an ammonium hydroxide solvent, a hydrogenation catalyst and additive tetraalkylammonium or phosphonium hydroxide; catalyst selectivity; efficiency | INVISTA NORTH AMERICA S.A.R.L. | 2001-11-29 | — | — | US | disclosed |
| US-6258745-B1 | PARTIAL HYDROGENATION OF A DINITRILE USING CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-07-10 | — | — | US | disclosed |
| EP-1062200-A1 | AMINONITRILE PRODUCTION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-12-27 | — | — | EP | disclosed |
| WO-2000064862-A2 | PROCESS FOR HYDROGENATING DINITRILES IN AMINONITRILES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-11-02 | — | — | WO | disclosed |
| US-6080884-A | HYDROGENATING A DINITRILE WITH A HYDROGEN-CONTAINING FLUID IN THE PRESENCE OF A SOLVENT AND A METAL CATALYST; EFFICIENCY, BY-PRODUCT INHIBITION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-06-27 | — | — | US | disclosed |
| US-5986127-A | HYDROGENATION OF DINITRILE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-11-16 | — | — | US | disclosed |
| WO-1999047492-A1 | AMINONITRILE PRODUCTION | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-09-23 | — | — | WO | disclosed |
| US-4389333-A | Bisguanamine | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1983-06-21 | — | — | US | disclosed |
| US-4339578-A | STABILIZERS FOR FORMALDEHYDE | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1982-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10144752-B2 | Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins | NIT2, NCLN, NPM1 | ALDH1A1 4849/4885TDP1 3539/4885TSHR 3542/4885 |
| US-20160168180-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | NIT2, NCLN, NPM1 | ALDH1A1 4849/4885TDP1 3539/4885TSHR 3542/4885 |
| US-20170305945-A1 | Phosphinyl Amidine Compounds, Metal Complexes, Catalyst Systems, and Their Use to Oligomerize or Polymerize Olefins | NIT2, NCLN, NPM1 | ALDH1A1 4849/4885TDP1 3539/4885TSHR 3542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.